| FOR RELEASE ON | 24 April 2025 |
IP Group plc - Results of General Meeting
A General Meeting ("GM") of IP Group plc was held earlier today. The Resolution proposed at the GM was passed by the appropriate majority on a poll.
IP Group plc General Meeting Poll Results
|
| RESOLUTION | VOTES | % | VOTES | % | VOTES | % of ISC VOTED | VOTES |
| 1 | To authorise the Company to make market purchases of its own shares, subject to specified limits | 664,664,672
|
99.98
| 146,663
| 0.02
| 664,811,335
| 70.54%
| 150,600
|
In accordance with Listing Rule 9.6.1, a copy of the Resolutions has been submitted to the National Storage Mechanism and will shortly be available for inspection at: www.fca.org.uk/markets/primary-markets/regulatory-disclosures/national-storage-mechanism.
For more information, please contact:
| IP Group plc | |
| Liz Vaughan-Adams, Communications | +44 (0) 20 7444 0062/+44 (0) 7979 853802 |
| Portland | |
| Alex Donaldson | +44 (0) 7516 729702 |
Notes for editors
About IP Group
IP Group accelerates the impact of science for a better future. As the most active UK based, early stage science investor, we develop and support some of the world's most exciting businesses in deeptech, life sciences and cleantech (led by Kiko Ventures). Through Parkwalk, the UK's largest growth EIS fund manager, we also back world-changing innovation emerging in leading universities and research institutions. Our specialist investment team combines sector expertise with an international approach. Together we have a strong track record of success, having backed high-profile companies including Oxford Nanopore Technologies plc, First Light Fusion, Hysata, and Oxa. IP Group is listed on the Main Market of the London Stock Exchange under the code IPO.
For more information, please visit our website at www.ipgroupplc.com.
ENDS
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
